Showing results (601-610 of 688) with videos related to

Sort By:
Pageof 69
Vaccine|April 7, 2015
Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trialJosefina B Cadorna-Carlos, Terry Nolan, Charissa Fay Borja-Tabora, et al.
Annals of the Rheumatic Diseases|November 5, 2020
Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritisRoy M Fleischmann, Ricardo Blanco, Stephen Hall, et al.
RMD Open|November 14, 2020
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature researchAndreas Kerschbaumer, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases|February 11, 2025
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases a systematic literature review informing the 2024 update of an international consensus statementVictoria Konzett, Josef S Smolen, Peter Nash, et al.
Rheumatology and Therapy|November 17, 2020
Efficacy and Safety of Ixekizumab with or Without Methotrexate in Biologic-Naïve Patients with Psoriatic Arthritis: 52-Week Results from SPIRIT-H2H StudyJosef S Smolen, Anthony Sebba, Eric M Ruderman, et al.
JAMA Internal Medicine|March 2, 2026
Diacerein for Knee Osteoarthritis: A Randomized Clinical TrialDawn Aitken, Guoqi Cai, Catherine L Hill, et al.
Annals of the Rheumatic Diseases|February 11, 2025
Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases - a systematic literature review informing the 2024 update of an international expert consensus statementVictoria Konzett, Josef S Smolen, Peter Nash, et al.
RMD Open|April 26, 2016
PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritisSusan Lester, Alex W Hewitt, Carlee D Ruediger, et al.
Osteoarthritis and Cartilage Open|April 21, 2026
Implementing good life with OsteoArthritis from Denmark (GLA:D®) in public outpatient settings in Tasmania, AustraliaYoseph M Alamneh, Laura Sutton, Christian Barton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 10, 2020
Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III StudyAtul Deodhar, Ricardo Blanco, Eva Dokoupilová, et al.
Pageof 69